Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
Michael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
The Journal of Experimental Medicine
|
May 5, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels
Meidi Gu, Kaitlin A Read, Vipin Bhardwaj, et al.
The Journal of Clinical Investigation
|
August 21, 2020
Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K Lundgren, Xuming Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors
Edmund K Moon, Liang-Chuan Wang, Douglas V Dolfi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito, Michael C Milone, Raffit Hassan, et al.
Blood Advances
|
May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Tina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Blood Cancer Discovery
|
August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma
Kavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
Immunity
|
August 27, 2017
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U Kawalekar, Roddy S O' Connor, Joseph A Fraietta, et al.
British Journal of Haematology
|
March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy
Luca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design
Saba Ghassemi, Francisco J Martinez-Becerra, Alyssa M Master, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
Michael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
The Journal of Experimental Medicine
|
May 5, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels
Meidi Gu, Kaitlin A Read, Vipin Bhardwaj, et al.
The Journal of Clinical Investigation
|
August 21, 2020
Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K Lundgren, Xuming Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors
Edmund K Moon, Liang-Chuan Wang, Douglas V Dolfi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito, Michael C Milone, Raffit Hassan, et al.
Blood Advances
|
May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Tina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Blood Cancer Discovery
|
August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma
Kavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
Immunity
|
August 27, 2017
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U Kawalekar, Roddy S O' Connor, Joseph A Fraietta, et al.
British Journal of Haematology
|
March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy
Luca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design
Saba Ghassemi, Francisco J Martinez-Becerra, Alyssa M Master, et al.
Page
of 11